Literature DB >> 15802124

Calculating the probability of detection for inhibitors in enzymatic or binding reactions in high-throughput screening.

Stephen Buxser1, Steven Vroegop.   

Abstract

In high-throughput screening (HTS) for drug candidates from a library containing tens of thousands to millions of chemical compounds, one problem is assessing the sensitivity of an assay for detecting compounds with a particular potency. For example, when looking for inhibitors of an enzyme, what is the potency of an inhibitor that will be readily detected by an enzyme inhibition assay? Similarly, when assessing compounds that inhibit binding between receptors and ligands or similar molecule-to-molecule interactions, what potency of an inhibitor will be readily detected? In this article, the well-established concepts of Michaelis-Menten kinetics and Langmuir binding isotherms are combined with fundamental statistical principles to yield a measure of assay sensitivity. The approach is general and can be modified to accommodate situations where the reaction kinetics is known to be more complicated than situations described by the Michaelis-Menten and Langmuir equations. The calculations presented take into account the concentration of inhibitor used, the variability of the assay, the relationship between the K(m) or K(d) of the reaction and the substrate or ligand concentration used, the threshold or cutoff value used for determining "hits," and the number of replicates used in screening.

Mesh:

Substances:

Year:  2005        PMID: 15802124     DOI: 10.1016/j.ab.2005.01.034

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  5 in total

1.  Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries.

Authors:  James Inglese; Douglas S Auld; Ajit Jadhav; Ronald L Johnson; Anton Simeonov; Adam Yasgar; Wei Zheng; Christopher P Austin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

2.  A novel fluorescence intensity screening assay identifies new low-molecular-weight inhibitors of the gp41 coiled-coil domain of human immunodeficiency virus type 1.

Authors:  Lifeng Cai; Miriam Gochin
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

3.  Dose-response modeling of high-throughput screening data.

Authors:  Fred Parham; Chris Austin; Noel Southall; Ruili Huang; Raymond Tice; Christopher Portier
Journal:  J Biomol Screen       Date:  2009-12

4.  A double-headed cathepsin B inhibitor devoid of warhead.

Authors:  Patricia Schenker; Pietro Alfarano; Peter Kolb; Amedeo Caflisch; Antonio Baici
Journal:  Protein Sci       Date:  2008-09-16       Impact factor: 6.725

5.  Targeting an Essential GTPase Obg for the Development of Broad-Spectrum Antibiotics.

Authors:  Josephine A Bonventre; Ryszard A Zielke; Konstantin V Korotkov; Aleksandra E Sikora
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.